ArticleOncoTargets and therapy2020
Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of
Shuna Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.